STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

Why only for healthcare professionals?

The content on these information pages is directed solely at you if you are a doctor, nurse, or pharmacist, as it concerns treatment with prescription medicines.

Please confirm that you are a healthcare professional (healthcare assistant, nurse, doctor, psychologist, or other licensed healthcare professional).

Back to main page

Confirm and continue

News
August 29, 2025

Discover Annest's sustainable weight loss journey with Yazen

Busy mum Annest found sustainable weight loss with Yazen. Four months in, she's healthier, confident, and embracing a positive, lasting lifestyle change.

Weight loss breakthrough: how one woman lost 1.5 stone with Wegovy

Annest Dalby's weight loss journey is a testament to the potential of modern medical interventions. After years of struggling with her weight and trying numerous diets, including WeightWatchers, Slimming World, and the "fairly extreme" Cambridge Diet, Annest has found success with the weight-loss medication Wegovy alongside Yazen.

A transformative personal experience

Since mid-May, Annest has lost an impressive 21 pounds using semaglutide, the active ingredient in Wegovy. However, her transformation goes far beyond mere numbers. She describes the medication as life-changing, comparing it to "having a brain transplant" and completely eliminating what she calls "food noise" – the constant, overwhelming thoughts about eating that had dominated her life for years.

Understanding the medication

Wegovy works by targeting the brain's reward system, helping patients feel fuller and reducing the constant preoccupation with food. Dr Elin Skoglund from Yazen explains that the medication can provide a sense of relief by diminishing the distractions of constant food thoughts.

The medication is not a magic solution but a tool for those with specific health needs. The NHS prescribes Wegovy only for individuals with weight-related health problems and a certain body mass index (BMI). It must be used in combination with diet and exercise and is particularly helpful for those who have struggled to lose weight through traditional methods.

Annest's personal history adds depth to her success – she has an underactive thyroid, a condition triggered during her second pregnancy, which had previously made weight loss challenging. Despite these obstacles, Wegovy has provided her with a breakthrough.

Potential side effects and professional guidance

While Annest's experience is overwhelmingly positive, medical professionals like Dr Deborah Lee caution that the medication can have side effects. These may include nausea, diarrhea, vomiting, constipation, stomach pain, and bloating. As with any medical treatment, it's crucial to consult healthcare professionals and undergo careful monitoring.

A broader perspective on weight management

The British Heart Foundation has noted additional benefits of Wegovy, including its potential to lower the risk of heart attacks and strokes in patients with heart and circulatory diseases. This highlights that weight management medications can offer benefits beyond weight loss.

Annest's story is more than just a weight loss success – it's a narrative of reclaiming control, reducing mental stress around eating, and improving overall quality of life.

If you’d like to hear more about Annest's Yazen journey, check out her patient testimonial here.

Read the full article here.

More news

Yazen achieved record-breaking growth in 2025, doubling its revenue.

In 2025, Yazen's revenue surged 87% to nearly €29.4 million, with gross profits doubling to €16.5 million. Now treating over 37,000 active patients across seven countries, the company is eyeing further expansion into two more markets in 2026. Despite an EBITDA of –€5.7 million due to heavy growth investment, Yazen remains a leader in European obesity care.

Yazen presents new data on digital obesity care at NOM 2026

Yazen presents an oral scientific abstract at the Nordic Obesity Meeting (NOM26), highlighting high-volume patient–caregiver interactions in a fully digital obesity care model.

Yazen Highly Commended in the HTN Now 2025/26 Awards

Yazen’s work powering digital patient transformation for sustainable weight care is recognised by the HTN Now 2025/26 Awards in the category of Digital Patient Transformation.